20
Generics International Ventures Enterprises Llc, based in U.S.A, is a pharmaceutical company.
One of their notable products is BISMUTH SUBCITRATE POTASSIUM, with a corresponding US DMF Number 28358.
Remarkably, this DMF maintains an Active status since its submission on June 11, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 07, 2015, and payment made on June 13, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II